Beta lactam + Tetracycline Rapid Test is a competitive immunoassay for the semi-quantitative detection of the presence of Beta lactam and Tetracycline residue in milk.
KIT COMPONENT
1.6 plastic canister each containing 8 microwells and 8 strips
One-Step HBsAg Rapid Test is to detect the Hepatitis B Virus Surface Antigen in serum, plasma or whole blood.
Analytical sensitivity : 1ng/ml of HBsAg
Sensitivity :100% , Specificity : 100%
Specimen : Serum , Plasma or Whole Blood
Reading Time : 10 min
The HIV-1/2 Rapid Screen Test (RST) is a qualitative test for the detection of antibodies to Human Immunodeficiency Virus type 1 and 2(HIV-1/2) in human serum/plasma and whole blood. It is considered as an initial screening test for HIV-1/2 antibodies. All positive specimens must be confirmed with Western Blot or other qualified EIA.
PRECAUTION
1.For in vitro diagnostic uses only.
2.All patient samples should be treated as if capable of transmitting diseases.
3.Do not use test kit beyond expiration date.
4.Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results.
SUMMARY AND EXPLANATION OF THE TEST
It has been shown that the acquired immunodeficiency syndrome (AIDS) is caused by viruses transmitted by sexual contact, transfusion, use of contaminated blood products and sharing contaminated needles. HIV-1 and HIV-2 viruses have been isolated from patients with AIDS and AIDS-related complex (ARC), high-risk persons for AIDS. HIV-1 and HIV-2 viruses delete T helper cells, a subpopulation of T cells for body defense, thus causing AIDS patients susceptible to opportunistic infections and developing malignant tumors. The incidence of specific antibodies to HIV-1/2 is high in AIDS, ARC and persons with high risk for AIDS. The HIV-1/2 Rapid Screen Test is designed to detect antibodies to HIV-1/2 in AIDS patients, ARC or high risk persons and identify any potential donors carrying these antibodies in serum specimens.
PRINCIPLE
HIV-1/2 RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HIV-1/2 in human serum/plasma and whole blood. HIV-1/2 specific antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HIV-1/2 specific antigens. Antibodies to HIV-1/2, if present, a red colored band will develop on the membrane in proportion to the amount of HIV-1/2 antibodies present in the specimen. Absence of this red colored band in the test region suggests a negative result. To serve as a procedural control, red colored band in the control region will always appear regardless the presence of antibodies to HIV-1/2.
INTENDED USE
Canine Distemper Virus Ag Test is a sandwich lateral flow immunochromatographic assay for the qualitative
detection of canine Distemper virus (CDV Ag) in dog's secretions or serum.
Assay Time: 5-10 min
Sample: secretions or serum
PRINCIPLE
Canine Distemper Virus Ag Test is based on sandwich lateral flow immunochromatographic assay. The test
device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When
sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test
strip. If there is enough Distemper antigen in the sample, a visible T band will appear. The C band should
always appear after a sample is applied, indicating a valid result. By this means, the device can accurately
indicate the presence of Canine Distemper antigen in the sample.
Our test kit has been approved and endorsed by Singapore's MOH (Ministry of Health) and HSA (Health Science Authority) since last year and we have been constantly supplying to the APAC countries during this period. (Japan, India, Singapore, Malaysia, Indonesia and etc.)
* CE mark was attained in December 2020. *
Our Tepat 1.0 SARS-CoV-2 RT-PCR provides for high-throughput, sensitive and specific detection of SARS-CoV-2 RNA extracted from nasopharyngeal swabs*.
It can detect 6 copies of viral RNA per reaction with > 95% confidence. Clinical validation shows 100% sensitivity, with no cross-reaction with non-SARS-CoV-2 species.
Key Highlights
1.5 hours from RNA to results
Multiplex RdRp and M viral genes detection enhances sensitivity and specificity
100% coverage with 100% identity of all SARS-CoV-2 genomes in the world
Detects 6 copies of viral RNA
Whole process control: human RNase P
COVID-19 RT-PCR TEST - NO RNA PURIFICATION NEEDED!
Results in less than 60 minutes, very easy-to-use.
Made in USA, with clinical validations all over the world.
FDA-EUA approved and CE cleared.
USA Manufactured, highly accurate, rapid COVID-19 Antigen test. Clinically validated by third-party medical institutions in USA and Europe (Denmark, Poland). The test is highly specific and sensitive (Specificity 100%, Sensitivity 99.1%). Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging.
Manufcatured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 & Flu (influenza A&B) rapid antigen test. Clinically validated on large patient cohorts. The test is highly specific and sensitive: COVID-19: Sensitivity 99.1%, Specificity 99.5% Influenza A: Sensitivity 93.1%, Specificity 98.41% Influenza B: Sensitivity 94.2%, Specificity 98.59%
Florida. Manufacturer has a decade of experience in rapid testing. Has CE.
Available in either bulk or home-use packaging. Manufactured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 Antibody test. Clinically validated in the USA by Harvard and UCSF Universities, and found to be best-in-class of Antibody tests. 95-100% accuracy in identifying patients after days 12. Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging.
Manufcatured and ships out of Miami, Florida.
Fully Automated Nucleic Acid Extraction And Real Time, Pcr System, Fully Automated Nucleic Acid Extraction System, Real Time Pcr System, Detection Kit.
